Brain Cancer | Clinical

Hispanic Pediatric Patient With Neuroblastoma Show Worse Overall Survival

May 27, 2022

After identifying a survival disparity among non-White Hispanic patients with pediatric neuroblastoma, investigators will next examine the interaction of survival and race, ethnicity, and poverty, acknowledging the intersectionality of these factors due to structural racism in the United States.

Brain Cancer Awareness Month: Advances in the Glioblastoma Landscape

May 18, 2022

In an interview with Targeted Oncology, Stephen M. Karlovits, MD, discussed key developments that researchers have made in the primary brain tumor treatment landscape in recent years and upcoming trials with potential to improve outcomes for patients.